These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 865132

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R, Amery A, Ljnen P, Reybrouck T, Billiet L.
    Prog Biochem Pharmacol; 1976 Aug; 12():242-9. PubMed ID: 1019167
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery.
    Romero JC, Holmes DR, Strong CG.
    Circ Res; 1977 May; 40(5 Suppl 1):I17-23. PubMed ID: 870227
    [Abstract] [Full Text] [Related]

  • 8. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
    Mimran A, Deschodt G, Fourcade J, Barjon P.
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():16-21. PubMed ID: 119507
    [Abstract] [Full Text] [Related]

  • 9. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate].
    Mimran A, Deschodt G, Shaldon S, Barjon P, Mion C.
    Arch Mal Coeur Vaiss; 1978 Jul; 71 Spec No():19-24. PubMed ID: 101176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T, Zschierdrich H, Distler A.
    Klin Wochenschr; 1977 Sep 15; 55(18):917-9. PubMed ID: 916618
    [Abstract] [Full Text] [Related]

  • 12. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients].
    Bönner G, Lang R, Hummerich W, Helber A, Meurer KA, Wambach G, Kaufmann W.
    Med Welt; 1980 Sep 19; 31(38):1362, 1363-5. PubMed ID: 7001167
    [No Abstract] [Full Text] [Related]

  • 13. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A, Hummerich W, Bönner G, Meurer KA, Moritz G.
    Verh Dtsch Ges Kreislaufforsch; 1977 Sep 19; 43():208-9. PubMed ID: 613575
    [No Abstract] [Full Text] [Related]

  • 14. Production of sustained hypertension by chronic intrarenal norepinephrine infusion in conscious dogs.
    Katholi RE, Carey RM, Ayers CR, Vaughan ED, Yancey MR, Morton CL.
    Circ Res; 1977 May 19; 40(5 Suppl 1):I118-26. PubMed ID: 870220
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J, Liebau G, Steiner B, Hayduk K.
    Klin Wochenschr; 1978 Sep 01; 56(17):859-64. PubMed ID: 713415
    [Abstract] [Full Text] [Related]

  • 17. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ, Lever AF, Millar JA, Morton JJ, Slack B.
    Lancet; 1978 Sep 01; 2(8052-8053):1317-9. PubMed ID: 74729
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH, Bönner G, Gram N, Mann JF, Helber A, Ganten D.
    Klin Wochenschr; 1978 Sep 01; 56 Suppl 1():97-105. PubMed ID: 732257
    [Abstract] [Full Text] [Related]

  • 19. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JI, White RP, Sealey JE, Laragh JH.
    Am J Med; 1976 Nov 01; 61(5):790-6. PubMed ID: 185903
    [Abstract] [Full Text] [Related]

  • 20. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A, Shaldon S, Barjon P, Mion C.
    Clin Nephrol; 1978 Feb 01; 9(2):63-7. PubMed ID: 639368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.